Turning cancer defects into cures

With a team of 70 scientists from 22 different nations we turn cancer defects into novel treatments. Subscribe to our newsletter to stay updated about our research!

Welcome to the Helleday Laboratory

Targeting DNA Glycosylase OGG1 in inflammation

Read more

We aim to improve science, health and society! Our commitment does not stop with science at the basics; we bring our results all the way to the patients.

The Helleday Laboratory consists of a large team of mixed professions from industry and academia; basic molecular biologists, medicinal chemists, pharmacologists, biochemists and practicing clinicians, amongst others. What brings us together is our dedication to make our basic science discoveries reach all the way to helping patients stay healthy and with their loved ones.

The Helleday Laboratory mostly focuses on metabolism and DNA repair, and recently inflammation.

The Nobel Prize laureate Otto Warburg who pioneered modern cancer metabolism research once said that “The cure of human cancer will be the resultant of biochemistry of cancer and of biochemistry of man“. We could not agree more. With today’s molecular knowledge of altered metabolic pathways in cancer cells we are making real advances in progressing cancer treatments. Read about how we target glucose metabolism and nucleotide metabolism. Chemo- and radiotherapy is still the backbone of cancer treatments, and they work by causing damage to the cancer cells DNA. We know today that cancer cells have a high load of DNA damage as compared to normal cells. Read about DNA damage and repair in cancer. Previously, the Helleday lab has exploited this and shown that PARP inhibitors selectively kill recombination defective cancers, such as inherited breast- and ovarian cancer. This is now an approved treatment and help patients across the world.


Biberach students visit the labs

On 25th of September a group of around 40 bachelor students of the Biberach University of Applied Sciences from Germany visited the HelledayLab. The university is known for its strong practical education in subjects such as pharmaceutical biotechnology and thus it is...

Prize for best talk

At the Department of Oncology and Pathology Kick-Off event at Piperska Muren, Nadilly Bonagas and Nina Gustafsson won the prize for the best talk with “Targeting Metabolic Remodeling in AML”. The day offered exciting presentations, poster sessions, lively...

Summer is over, what is up next?

With the swedish summer being over and people returning to the lab, the second half of the academic year 2018 is starting with some exciting conferences and symposia. On 29th of August, the Department of Oncology and Pathology will “Kick-Off” the new...


It is time to say goodbye. During the last ten months ,the Helleday lab had a great time not only hosting, but also working with our very talented and driven exchange interns Pepy Iliev and Dag Ivanic. They were involved in several impactful medicinal chemistry and...

The Helleday Laboratory is expanding to Sheffield in the UK to synergize with existing labs in Sweden to further enable pre-clinical drug discovery work to be implemented in an academic-driven clinical environment.

The Helleday Laboratory is now taking a new step forward and is set to expand to Sheffield in the UK in an emerging new cancer initiative that would bring clinicians and pre-clinical scientists closer together to foster a culture of collaboration across disciplines...

“I am happy and impressed by your work. Words can not describe how grateful I am; not only for my sake but for my children and family as well. It gives me hope to break the chain of cancer in the family. I hope for the drug to reach the market soon so more patients can be treated.” Translated from Swedish



Our vision

Many diseases have alterations in metabolic pathways often leading to DNA damage that manifest or define the disease. Our strategy is to identify basic mechanisms of proteins involved in metabolism and DNA repair to gain better understanding in disease and also develop small molecule inhibitors to selectively targeting these proteins as potential therapeutics. We reach our goal through open innovation and through a foundation, securing the future for our science and ensuring long term benefit to mankind.

Our mission

We turn cancer defects into novel treatments. Cancer cells already have altered metabolic activity and a lot of DNA damage. With specific metabolic or DNA repair inhibitors we force the cancer cell into a trap where they cannot cope with the overload of DNA damage, without harming healthy cells with normal metabolic pathways.

There are 2 major kinds of motorcycle chanel replica saddlebags. Throw over saddlebags and hard mount saddlebags. The concept of hard mount saddlebags originated from throw over saddlebags which were used in early 1950 for your first time. As the motorcycle business experienced a big boom in 1960 especially after the chanel replica sale the motorcycle luggage also evolved. As major motorcycle companies launched bigger and better motorcycle folks chanel replica sale began traveling farther on there motorcycles. Many riders formed groups and chanel replica rode cross country and from city to city. Chanel replica handbags outlet is your trusting choosing. This permanent installation resulted in the saddlebags is more reliable and sturdy.